Early Detection Research Network

DNA methylation screening of primary prostate tumors identifies SRD5A2 and CYP11A1 as candidate markers for assessing risk of biochemical recurrence.

No abstract available.

Abboud-Werner SL, Awe JA, Chen CL, Chen Y, Drachenberg D, Hernandez J, Horning AM, Huang TH, Jadhav RR, Jin VX, Kroczak T, Lai Z, Leach RJ, Lin CL, Liu J, Louie AD, Mai S, Saranchuk J, Thompson IM, Wang CM, Wang VY


Prostate, 2015, 75 (15)